メニュー 戻るLS08 How RWE Affects Decision Making During the COVID-19 Pandemic

19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

価格は消費税抜きとなっております。

LS08 How RWE Affects Decision Making During the COVID-19 Pandemic

Session Chair(s)

Yoshiaki Uyama, PhD, RPh

Yoshiaki Uyama, PhD, RPh

  • Director, Office of Medical Informatics and Epidemiology
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Speaker(s)

Gerald J. Dal Pan, MD, MHS

Gerald J. Dal Pan, MD, MHS

  • Director, Office of Surveillance and Epidemiology, CDER
  • FDA, United States
Maria Gordillo-Marañon

Maria Gordillo-Marañon

  • European Medicines Agency, Netherlands
Chieko Ishiguro, PhD, MPH

Chieko Ishiguro, PhD, MPH

  • Section Chief,Section of Clinical Epidemiology Department of Data Science Cente
  • National Center for Global Health and Medicine, Japan